Clinical Trial Update: Ranibizumab Treatment for Retinal Vein Occlusion [NA]

View source ↗

Summary

This document concerns ranibizumab for macular edema due to branch retinal vein occlusion or central retinal vein occlusion. The trial status is currently unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Central Retinal Vein Occlusion

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Kyoto University, Graduate School of Medicine | Conditions: Macular Edema Due to BRVO/CRVO | NA | Status: UNKNOWN